Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study.
Triggiani L, Mazzola R, Magrini SM, Ingrosso G, Borghetti P, Trippa F, Lancia A, Detti B, Francolini G, Matrone F, Bortolus R, Fanetti G, Maranzano E, Pasqualetti F, Paiar F, Bonù ML, Magli A, Bruni A, Mazzeo E, Franzese C, Scorsetti M, Alongi F, Jereczek-Fossa BA, Ost P, Buglione M. Triggiani L, et al. Among authors: matrone f. World J Urol. 2019 Dec;37(12):2631-2637. doi: 10.1007/s00345-019-02717-7. Epub 2019 Mar 11. World J Urol. 2019. PMID: 30859273
Partial prostate re-irradiation for the treatment of isolated local recurrence of prostate cancer in patients previously treated with primary external beam radiotherapy: short-term results of a monocentric study.
Matrone F, Revelant A, Fanetti G, Polesel J, Chiovati P, Avanzo M, De Renzi F, Colombo CB, Arcicasa M, De Paoli A, Franchin G, Bortolus R. Matrone F, et al. Neoplasma. 2021 Jan;68(1):216-226. doi: 10.4149/neo_2020_200622N651. Epub 2020 Oct 7. Neoplasma. 2021. PMID: 33030959
Radical Hemithoracic Radiotherapy Versus Palliative Radiotherapy in Non-metastatic Malignant Pleural Mesothelioma: Results from a Phase 3 Randomized Clinical Trial.
Trovo M, Relevant A, Polesel J, Muraro E, Barresi L, Drigo A, Baresic T, Bearz A, Fanetti G, Del Conte A, Matrone F, Reverberi C, Furlan C, Zuccon U, Fontana P, Franchin G, Minatel E. Trovo M, et al. Among authors: matrone f. Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1368-1376. doi: 10.1016/j.ijrobp.2020.11.057. Epub 2020 Nov 28. Int J Radiat Oncol Biol Phys. 2021. PMID: 33259933 Clinical Trial.
Prognostic Nutritional Index Predicts Toxicity in Head and Neck Cancer Patients Treated with Definitive Radiotherapy in Association with Chemotherapy.
Fanetti G, Polesel J, Fratta E, Muraro E, Lupato V, Alfieri S, Gobitti C, Minatel E, Matrone F, Caroli A, Revelant A, Lionello M, Zammattio Polentin V, Ferretti A, Guerrieri R, Chiovati P, Bertolin A, Giacomarra V, Paoli A, Vaccher E, Sartor G, Steffan A, Franchin G. Fanetti G, et al. Among authors: matrone f. Nutrients. 2021 Apr 13;13(4):1277. doi: 10.3390/nu13041277. Nutrients. 2021. PMID: 33924581 Free PMC article.
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance.
Triggiani L, Mazzola R, Tomasini D, Bruni A, Alicino G, Matrone F, Bortolus R, Francolini G, Detti B, Magli A, Bonù ML, Ingrosso G, Lancia A, Trippa F, Maranzano E, Franzese C, Ghirardelli P, Vavassori V, Scorsetti M, Alongi F, Magrini SM. Triggiani L, et al. Among authors: matrone f. Med Oncol. 2021 May 18;38(6):72. doi: 10.1007/s12032-021-01518-6. Med Oncol. 2021. PMID: 34008151 Free PMC article.
Postoperative radiotherapy after upfront radical prostatectomy: debated issues at a turning point-a survey exploring management trends on behalf of AIRO (Italian Association of Radiotherapy and Clinical Oncology).
Francolini G, Timon G, Matrone F, Marvaso G, Nicosia L, Ognibene L, Vinciguerra A, Trodella LE, Franzese C, Borghetti P, Jereczek-Fossa BA, Arcangeli S. Francolini G, et al. Among authors: matrone f. Clin Transl Oncol. 2021 Dec;23(12):2568-2578. doi: 10.1007/s12094-021-02665-y. Epub 2021 Jul 21. Clin Transl Oncol. 2021. PMID: 34286475
32 results